Danielle Keatley
Investor Relations Contact en STRUCTURE THERAPEUTICS INC. .
Perfil
Danielle Keatley is currently the Head-Investor Relations at Structure Therapeutics, Inc. Previously, she worked as the Head-Media Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
She also served as the Head-IR & Corporate Communications at Ultragenyx Pharmaceutical, Inc. from 2016 to 2021.
Cargos activos de Danielle Keatley
Empresas | Cargo | Inicio |
---|---|---|
STRUCTURE THERAPEUTICS INC. | Investor Relations Contact | - |
Antiguos cargos conocidos de Danielle Keatley.
Empresas | Cargo | Fin |
---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01/08/2021 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
STRUCTURE THERAPEUTICS INC. | Commercial Services |
Empresas privadas | 1 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Danielle Keatley